Charles Schwab Investment Management Inc Singular Genomics Systems, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.78 - $1.28 $98,962 - $162,400	-126,875 Reduced 84.38%	23,488 $19,000
Q4 2022 Feb 13, 2023	BUY	$1.82 - $2.71 $10,601 - $15,785	5,825 Added 4.03%	150,363 $302,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.73 $55,115 - $104,277	22,046 Added 18.0%	144,538 $362,000
Q2 2022 Aug 15, 2022	BUY	$2.86 - $6.44 $36,299 - $81,736	12,692 Added 11.56%	122,492 $468,000
Q1 2022 May 13, 2022	BUY	$5.94 - $12.09 $465,731 - $947,928	78,406 Added 249.75%	109,800 $693,000
Q4 2021 Feb 11, 2022	BUY	$10.45 - $16.9 $22,133 - $35,794	2,118 Added 7.23%	31,394 $363,000
Q3 2021 Nov 16, 2021	BUY	$10.9 - $27.63 $319,108 - $808,895	29,276 New	29,276 $328,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.41B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.